Viewing StudyNCT05160922



Ignite Creation Date: 2024-05-06 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05160922
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-26
First Post: 2021-12-06

Brief Title: Crizotinib Continuation Clinical Study
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-12-27
Start Date Type: ACTUAL
Primary Completion Date: 2028-03-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-03-15
Completion Date Type: ESTIMATED
First Submit Date: 2021-12-06
First Submit QC Date: December 6 2021
Study First Post Date: 2021-12-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-09
Last Update Post Date: 2024-06-26
Last Update Post Date Type: ACTUAL